GPCR19
GPCR19 (GPBA receptors, TGR5, GPBAR1, M-BAR) are G protein-coupled receptors (GPCRs) that are activated by bile acids. They are highly expressed in the gallbladder, ileum, and colon, and are important in the regulation of glucose and lipid metabolism, and energy utilization. Diseases associated with GPBAR1 include Sclerosing Cholangitis and Intrahepatic Cholestasis Of Pregnancy. Among its related pathways are Signaling by GPCR and Peptide ligand-binding receptors. Gene Ontology (GO) annotations related to this gene include G protein-coupled receptor activity and G protein-coupled bile acid receptor activity.
-
SB756050
Catalog No. A12759 TGR5 agonistSB756050 is a selective TGR5 agonist currently in phase 1clinical trials for the treatment of type 2 diabetes. Learn More -
INT-777
Catalog No. A21168 -
INT-767
Catalog No. A21494 dual FXR/TGR5 agonistINT-767 is a dual farnesoid X receptor (FXR)/TGR5 agonist with mean EC50s of 30 and 630 nM, respectively. Learn More -
TGR5-Receptor-Agonist
Catalog No. A13732 TGR5(GPCR19) agonistTGR5 Receptor Agonist is a potent TGR5(GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5). Learn More -
-
New
SBI-115
Catalog No. A17235 GPCR19 antagonistSBI-115 is a TGR5 (GPCR19) antagonist. SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5. Learn More -